_antonio
Director
Clinical
ECLA Estudios Cl?nicos Latinoam?rica
Italy
Biography
Antonio LambiaseClinical Development Antonio Lambiase joined MolMed in March 2007. He previously worked for over fifteen years at Roche in the areas of oncology and haematology as medical responsible for clinical development of several biological and molecular targeted compounds, including cancer biotherapeutics, haematopoietic growth factors, therapeutic monoclonal antibodies and antiangiogenesis agents. Before that, he spent three years as a research fellow at the Medical Oncology Unit of National Cancer Institute of Milan. Antonio Lambiase received his degree in Medicine from University of Naples, where he completed his postgraduate studies and specialisation.
Research Interest
Clinical
